Paronychia Treatment Guidelines

Introduction to Paronychia Treatment

The American Academy of Dermatology recommends topical povidone iodine 2% combined with topical antibiotics and corticosteroids as first-line therapy for paronychia treatment, with oral antibiotics reserved for cases with suspected infection or treatment failure 1, 2

For mild paronychia, apply topical povidone iodine 2% to the affected area daily, alternating with topical antibiotics and corticosteroid combinations, and implement antiseptic soaks with dilute vinegar for 10-15 minutes twice daily 1, 2, 3
For moderate paronychia, continue topical povidone iodine 2%, apply mid to high potency topical steroid ointment to nail folds twice daily, and consider topical beta-blocking agents for granulation tissue 1, 2, 3
For severe paronychia, interrupt causative factors, obtain bacterial/viral/fungal cultures, and consider partial nail avulsion for severe cases 1, 2, 3

For Candida-associated paronychia, topical imidazole lotions are first-line treatment, and oral itraconazole may be considered for nail plate invasion 4, 5, 6
For chronic paronychia, identify and eliminate irritant exposures, and consider combination therapy with insulating polymer, antifungals, and anti-inflammatory agents 2, 3

Keep hands dry, avoid trauma to nails, wear protective gloves, trim nails straight across, and apply emollients to periungual tissues regularly 1, 2

Avoid prolonged use of topical steroids without addressing underlying cause, and don't overlook potential secondary fungal infections 1, 2, 3
Remember that paronychia can be a side effect of anticancer therapies, requiring specific management approaches 1, 3

For Candida-associated chronic paronychia, topical imidazole lotions are first-line treatment, according to the Clinical Infectious Diseases guideline 7
Drainage is mandatory and the most important intervention for severe acute paronychia (established abscess), as recommended by the Clinical Infectious Diseases guideline 7

Itraconazole 200 mg daily or pulse therapy 400 mg daily for 1 week per month, repeated for 2-4 months, is the first-line treatment for Candida onychomycosis, according to the Clinical Infectious Diseases guideline 7
Terbinafine has limited and unpredictable activity against Candida and should be avoided, as stated by the Clinical Infectious Diseases guideline 7